Horizon Therapeutics Public Ltd Co

US BANCORP \DE\

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/3/2023

Shares

15,785

Value ($000)

1,826

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/3/2023	1,826	0.0%	15,785	9/30/2023
2023 Q2	8/10/2023	1,672	0.0%	16,254	6/30/2023
2023 Q1	5/9/2023	2,065	0.0%	18,918	3/31/2023
2022 Q4	2/13/2023	5,156	0.0%	45,309	12/31/2022
2022 Q3	10/27/2022	2,790	0.0%	45,089	9/30/2022
2022 Q2	8/1/2022	3,379	0.0%	42,359	6/30/2022
2022 Q1	5/11/2022	4,667	0.0%	44,359	3/31/2022
2021 Q4	2/11/2022	4,761	0.0%	44,180	12/31/2021
2021 Q3	11/10/2021	4,890	0.0%	44,647	9/30/2021
2021 Q2	8/5/2021	4,247	0.0%	45,365	6/30/2021
2021 Q1	4/28/2021	4,178	0.0%	45,385	3/31/2021
2020 Q4	2/4/2021	3,194	0.0%	43,653	12/31/2020
2020 Q3	11/10/2020	3,420	0.0%	44,012	9/30/2020
2020 Q2	8/7/2020	2,786	0.0%	50,110	6/30/2020
2020 Q1	5/13/2020	1,088	0.0%	36,713	3/31/2020
2019 Q4	2/4/2020	1,409	0.0%	38,910	12/31/2019